###begin article-title 0
Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
###end article-title 0
###begin p 1
Hypertrophic cardiomyopathy, a common, inherited cardiac muscle disease, is primarily caused by mutations in sarcomeric protein-encoding genes and is characterized by overgrowth of ventricular muscle that is highly variable in extent and location. This variability has been partially attributed to locus and allelic heterogeneity of the disease-causing gene, but other factors, including unknown genetic factors, also modulate the extent of hypertrophy that develops in response to the defective sarcomeric functioning. Components of the renin-angiotensin-aldosterone system are plausible candidate hypertrophy modifiers because of their role in controlling blood pressure and biological effects on cardiomyocyte hypertrophy.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
We investigated four Single Nucleotide Polymorphisms in the gene-encoding angiotensin converting enzyme 2 (ACE2), a gene on the X-chromosome whose RAAS product modulates cardiac structure and function, for association with hypertrophic traits in 227 individuals belonging to 22 HCM families with known founder disease-causing mutations.
###end p 3
###begin p 4
After adjustment for hypertrophy-influencing factors, including the particular disease-causing mutation, we find association between the G-allele of rs879922 and increased left ventricular mass (effect size: 18.7 g), maximum interventricular septal thickness (effect size: 1.9 mm) as well as maximum posterior wall thickness (effect size: 0.7 mm).
###end p 4
###begin p 5
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
These data demonstrate that ACE2 plays a role in modifying the extent of hypertrophy that develops in HCM, independent of the effect of the disease-causing mutation or blood pressure.
###end p 5
###begin p 6
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2001</xref>
###xml 387 392 <span type="species:ncbi:9606">human</span>
Hypertrophic cardiomyopathy (HCM; OMIM #192600) is a primary cardiac muscle disorder classically caused by mutations (>400) in genes encoding components of the thick and thin filaments of the cardiac sarcomere (). Extreme variability of the hypertrophic phenotype is a hallmark feature of HCM and has been attributed in part to allelic effects of the disease-causing gene. Evidence from human and transgenic animal studies indicates that the degree of hypertrophy that develops in response to the causal mutation is modified by environmental factors (including demographic factors such as age, sex and body size), as well as by other genetic factors (Semsarian et al. 2001).
###end p 6
###begin p 7
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2002</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2002</xref>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 881 885 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2006</xref>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2008</xref>
###xml 1245 1249 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 1037 1045 <span type="species:ncbi:9606">patients</span>
###xml 1324 1332 <span type="species:ncbi:9606">patients</span>
Genes within the renin-angiotensin-aldosterone system (RAAS) have been investigated as modifiers of the hypertrophic variability in HCM in recent years (Marian 2002; Ortlepp et al. 2002), and much emphasis has been placed on the possible role of the angiotensin-converting-enzyme (ACE) I in the development of hypertrophy. However, subsequently, a second ACE, ACEII, has been discovered and its product, viz. angiotensin-(1-7), has been found to antagonize the vasoconstriction mediated by its substrate, angiotensin II. Lieb et al. found that minor alleles of four single nucleotide polymorphisms (SNPs) in the X-chromosomally located ACEII gene (ACE2) were associated with increases in hypertrophic parameters, viz. left ventricular mass indexed to body size (LVMI), as well as end-diastolic interventricular septal wall thickness (IVS) in males, but not in females (Lieb et al. 2006). Subsequently, Wang et al. also reported that minor alleles of other SNPs in ACE2 were again associated with increased IVS in male but not female HCM patients (Wang et al. 2008). In the latter study, it is possible that the effect of the unknown HCM-causing mutations in the case cohort could confound the results. Hence, we aimed to investigate the role of ACE2 variants in the extent of hypertrophy that develops in genotype-known HCM patients belonging to families in which any of three South African HCM founder mutations segregate.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
Subjects
###end title 9
###begin p 10
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNNT2</italic>
###xml 252 257 252 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TNNT2</italic></sub>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYH7</italic>
###xml 266 270 266 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>MYH7</italic></sub>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYH7</italic>
###xml 283 287 283 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>MYH7</italic></sub>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2008</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1999</xref>
The study was approved by the University of Stellenbosch Health Sciences Faculty's Institutional Review Board (N04/03/062). Twenty-two consecutively referred index cases bearing one of the previously reported South African HCM-founder mutations (7 R92WTNNT2, 3 R403WMYH7 and 11 A797TMYH7) were identified and pedigree tracing was performed (Revera et al. 2008). Individuals who gave informed written consent were tested for carrier-status for each of the three founder mutations, as previously described (Moolman-Smook et al. 1999).
###end p 10
###begin title 11
Clinical evaluation
###end title 11
###begin p 12
###xml 871 875 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1989</xref>
###xml 917 921 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2008</xref>
###xml 373 384 <span type="species:ncbi:9606">participant</span>
Blood pressure was taken, twice: in the sitting position, after 5 min of bed rest, and the second measurement was used. Individuals were coded as hypertensive if they had systolic blood pressure >/=140 mm Hg, or diastolic blood pressure >/=90, or were on anti-hypertensive medication. Medical history, and demographic data (age, sex, height, weight) were recorded for each participant. We performed standard electrocardiography on a MAC1200ST after 5 min of rest in the supine position, and from this derived resting heart rate. Echocardiography was performed anew on all participating individuals, using a standardized procedure to measure the wall thickness in 16 left ventricular wall segments, by a single experienced echocardiographer (MR) who was blinded to mutation status, according to recommendations of the American Society of Echocardiography (Schiller et al. 1989), as previously described (Revera et al. 2008). LVM was calculated using the American Society of Echocardiography's recommended formula for estimation of LVM from 2D-LV linear dimensions:
###end p 12
###begin title 13
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
ACE2 genotyping
###end title 13
###begin p 14
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2006</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2005</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2006</xref>
As the LD structure of this (and other) regions of the genome has not been reported in the study population, we relied on density selection of SNPs. Four polymorphisms, viz. rs1978124 (intron 1), rs2285666 (intron 3), rs879922 (intron 11) and rs4646179 (exon 16), spread through the length of ACE2 at an average spacing of ~8 kb, were selected from dbSNP. These SNPs were chosen because they had been validated by frequency, had been found associated with cardiovascular traits in previous studies (Lieb et al. 2006; Liu et al. 2005; Yang et al. 2006) and were amenable to genotyping by means of restriction enzyme analysis.
###end p 14
###begin p 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1999</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 730 737 730 737 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 737 838 737 838 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="16">Summary of PCR-based allele-specific restriction enzyme analysis used for genotyping of <italic>ACE2</italic> variants</p>
###xml 737 838 737 838 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="16">Summary of PCR-based allele-specific restriction enzyme analysis used for genotyping of <italic>ACE2</italic> variants</p></caption>
###xml 838 845 838 845 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Variant</th>
###xml 845 860 845 860 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Primers (5&#8242;&#8211;3&#8242;)</th>
###xml 860 878 860 878 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Restriction enzyme</th>
###xml 878 896 878 896 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Amplicon size (bp)</th>
###xml 896 919 896 919 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Major allele sizes (bp)</th>
###xml 919 942 919 942 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Minor allele sizes (bp)</th>
###xml 942 958 942 958 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Detection method</th>
###xml 838 958 838 958 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Variant</th><th align="left">Primers (5&#8242;&#8211;3&#8242;)</th><th align="left">Restriction enzyme</th><th align="left">Amplicon size (bp)</th><th align="left">Major allele sizes (bp)</th><th align="left">Minor allele sizes (bp)</th><th align="left">Detection method</th></tr>
###xml 838 958 838 958 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Variant</th><th align="left">Primers (5&#8242;&#8211;3&#8242;)</th><th align="left">Restriction enzyme</th><th align="left">Amplicon size (bp)</th><th align="left">Major allele sizes (bp)</th><th align="left">Minor allele sizes (bp)</th><th align="left">Detection method</th></tr></thead>
###xml 958 967 958 967 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs1978124</td>
###xml 967 991 967 991 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">F: tcttcctggctccttctcagc</td>
###xml 991 994 991 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sau</italic>
###xml 991 997 991 997 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>Sau</italic>96I</td>
###xml 997 1002 997 1002 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">1,044</td>
###xml 1002 1010 1002 1010 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">T (1044)</td>
###xml 1010 1021 1010 1021 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">C (962, 82)</td>
###xml 1021 1049 1021 1049 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">1.5% Agarose electrophoresis</td>
###xml 958 1049 958 1049 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs1978124</td><td align="left">F: tcttcctggctccttctcagc</td><td align="left" rowspan="2"><italic>Sau</italic>96I</td><td align="left" rowspan="2">1,044</td><td align="left" rowspan="2">T (1044)</td><td align="left" rowspan="2">C (962, 82)</td><td align="left" rowspan="2">1.5% Agarose electrophoresis</td></tr>
###xml 1049 1049 1049 1049 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1049 1073 1049 1073 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R: accacaatggcagagaaaggg</td>
###xml 1049 1073 1049 1073 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">R: accacaatggcagagaaaggg</td></tr>
###xml 1073 1082 1073 1082 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs2285666</td>
###xml 1082 1105 1082 1105 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">F: gtttgtaacccagataatcc</td>
###xml 1105 1108 1105 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1105 1109 1105 1109 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>Alu</italic>I</td>
###xml 1109 1112 1109 1112 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">130</td>
###xml 1112 1119 1112 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">C (130)</td>
###xml 1119 1129 1119 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">T (78, 52)</td>
###xml 1129 1137 1129 1137 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">12% PAGE</td>
###xml 1073 1137 1073 1137 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs2285666</td><td align="left">F: gtttgtaacccagataatcc</td><td align="left" rowspan="2"><italic>Alu</italic>I</td><td align="left" rowspan="2">130</td><td align="left" rowspan="2">C (130)</td><td align="left" rowspan="2">T (78, 52)</td><td align="left" rowspan="2">12% PAGE</td></tr>
###xml 1137 1137 1137 1137 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1137 1160 1137 1160 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R: gttgaaacacacatatctgc</td>
###xml 1137 1160 1137 1160 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">R: gttgaaacacacatatctgc</td></tr>
###xml 1160 1168 1160 1168 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs879922</td>
###xml 1168 1191 1168 1191 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">F: ttgtgttaagatcttgtccc</td>
###xml 1191 1194 1191 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bfa</italic>
###xml 1191 1195 1191 1195 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>Bfa</italic>I</td>
###xml 1195 1198 1195 1198 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">188</td>
###xml 1198 1205 1198 1205 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">C (188)</td>
###xml 1205 1216 1205 1216 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">G (146, 42)</td>
###xml 1216 1224 1216 1224 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">12% PAGE</td>
###xml 1160 1224 1160 1224 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs879922</td><td align="left">F: ttgtgttaagatcttgtccc</td><td align="left" rowspan="2"><italic>Bfa</italic>I</td><td align="left" rowspan="2">188</td><td align="left" rowspan="2">C (188)</td><td align="left" rowspan="2">G (146, 42)</td><td align="left" rowspan="2">12% PAGE</td></tr>
###xml 1224 1224 1224 1224 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1224 1245 1224 1245 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R: aataaactgagctccagc</td>
###xml 1224 1245 1224 1245 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">R: aataaactgagctccagc</td></tr>
###xml 1245 1254 1245 1254 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs4646179</td>
###xml 1254 1277 1254 1277 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">F: tacagggaggaggatgtgcg</td>
###xml 1277 1280 1277 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpy</italic>
###xml 1277 1285 1277 1285 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>Hpy</italic>CH4IV</td>
###xml 1285 1288 1285 1288 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">680</td>
###xml 1288 1305 1288 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">T (328, 229, 123)</td>
###xml 1305 1326 1305 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">C (328, 152, 123, 77)</td>
###xml 1326 1354 1326 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">2.5% Agarose electrophoresis</td>
###xml 1245 1354 1245 1354 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs4646179</td><td align="left">F: tacagggaggaggatgtgcg</td><td align="left" rowspan="2"><italic>Hpy</italic>CH4IV</td><td align="left" rowspan="2">680</td><td align="left" rowspan="2">T (328, 229, 123)</td><td align="left" rowspan="2">C (328, 152, 123, 77)</td><td align="left" rowspan="2">2.5% Agarose electrophoresis</td></tr>
###xml 1354 1354 1354 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1354 1378 1354 1378 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R: tgatggcaatacctgtccacg</td>
###xml 1354 1378 1354 1378 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">R: tgatggcaatacctgtccacg</td></tr>
###xml 958 1378 958 1378 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">rs1978124</td><td align="left">F: tcttcctggctccttctcagc</td><td align="left" rowspan="2"><italic>Sau</italic>96I</td><td align="left" rowspan="2">1,044</td><td align="left" rowspan="2">T (1044)</td><td align="left" rowspan="2">C (962, 82)</td><td align="left" rowspan="2">1.5% Agarose electrophoresis</td></tr><tr><td align="left"/><td align="left">R: accacaatggcagagaaaggg</td></tr><tr><td align="left">rs2285666</td><td align="left">F: gtttgtaacccagataatcc</td><td align="left" rowspan="2"><italic>Alu</italic>I</td><td align="left" rowspan="2">130</td><td align="left" rowspan="2">C (130)</td><td align="left" rowspan="2">T (78, 52)</td><td align="left" rowspan="2">12% PAGE</td></tr><tr><td align="left"/><td align="left">R: gttgaaacacacatatctgc</td></tr><tr><td align="left">rs879922</td><td align="left">F: ttgtgttaagatcttgtccc</td><td align="left" rowspan="2"><italic>Bfa</italic>I</td><td align="left" rowspan="2">188</td><td align="left" rowspan="2">C (188)</td><td align="left" rowspan="2">G (146, 42)</td><td align="left" rowspan="2">12% PAGE</td></tr><tr><td align="left"/><td align="left">R: aataaactgagctccagc</td></tr><tr><td align="left">rs4646179</td><td align="left">F: tacagggaggaggatgtgcg</td><td align="left" rowspan="2"><italic>Hpy</italic>CH4IV</td><td align="left" rowspan="2">680</td><td align="left" rowspan="2">T (328, 229, 123)</td><td align="left" rowspan="2">C (328, 152, 123, 77)</td><td align="left" rowspan="2">2.5% Agarose electrophoresis</td></tr><tr><td align="left"/><td align="left">R: tgatggcaatacctgtccacg</td></tr></tbody>
###xml 838 1378 838 1378 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Variant</th><th align="left">Primers (5&#8242;&#8211;3&#8242;)</th><th align="left">Restriction enzyme</th><th align="left">Amplicon size (bp)</th><th align="left">Major allele sizes (bp)</th><th align="left">Minor allele sizes (bp)</th><th align="left">Detection method</th></tr></thead><tbody><tr><td align="left">rs1978124</td><td align="left">F: tcttcctggctccttctcagc</td><td align="left" rowspan="2"><italic>Sau</italic>96I</td><td align="left" rowspan="2">1,044</td><td align="left" rowspan="2">T (1044)</td><td align="left" rowspan="2">C (962, 82)</td><td align="left" rowspan="2">1.5% Agarose electrophoresis</td></tr><tr><td align="left"/><td align="left">R: accacaatggcagagaaaggg</td></tr><tr><td align="left">rs2285666</td><td align="left">F: gtttgtaacccagataatcc</td><td align="left" rowspan="2"><italic>Alu</italic>I</td><td align="left" rowspan="2">130</td><td align="left" rowspan="2">C (130)</td><td align="left" rowspan="2">T (78, 52)</td><td align="left" rowspan="2">12% PAGE</td></tr><tr><td align="left"/><td align="left">R: gttgaaacacacatatctgc</td></tr><tr><td align="left">rs879922</td><td align="left">F: ttgtgttaagatcttgtccc</td><td align="left" rowspan="2"><italic>Bfa</italic>I</td><td align="left" rowspan="2">188</td><td align="left" rowspan="2">C (188)</td><td align="left" rowspan="2">G (146, 42)</td><td align="left" rowspan="2">12% PAGE</td></tr><tr><td align="left"/><td align="left">R: aataaactgagctccagc</td></tr><tr><td align="left">rs4646179</td><td align="left">F: tacagggaggaggatgtgcg</td><td align="left" rowspan="2"><italic>Hpy</italic>CH4IV</td><td align="left" rowspan="2">680</td><td align="left" rowspan="2">T (328, 229, 123)</td><td align="left" rowspan="2">C (328, 152, 123, 77)</td><td align="left" rowspan="2">2.5% Agarose electrophoresis</td></tr><tr><td align="left"/><td align="left">R: tgatggcaatacctgtccacg</td></tr></tbody></table>
###xml 1378 1380 1378 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bp</italic>
###xml 1393 1397 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAGE</italic>
###xml 1378 1432 1378 1432 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="17"><italic>bp</italic> base pairs, <italic>PAGE</italic> polyacrylamide gel electrophoresis</p>
###xml 1378 1432 1378 1432 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="17"><italic>bp</italic> base pairs, <italic>PAGE</italic> polyacrylamide gel electrophoresis</p></table-wrap-foot>
###xml 730 1432 730 1432 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="16">Summary of PCR-based allele-specific restriction enzyme analysis used for genotyping of <italic>ACE2</italic> variants</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variant</th><th align="left">Primers (5&#8242;&#8211;3&#8242;)</th><th align="left">Restriction enzyme</th><th align="left">Amplicon size (bp)</th><th align="left">Major allele sizes (bp)</th><th align="left">Minor allele sizes (bp)</th><th align="left">Detection method</th></tr></thead><tbody><tr><td align="left">rs1978124</td><td align="left">F: tcttcctggctccttctcagc</td><td align="left" rowspan="2"><italic>Sau</italic>96I</td><td align="left" rowspan="2">1,044</td><td align="left" rowspan="2">T (1044)</td><td align="left" rowspan="2">C (962, 82)</td><td align="left" rowspan="2">1.5% Agarose electrophoresis</td></tr><tr><td align="left"/><td align="left">R: accacaatggcagagaaaggg</td></tr><tr><td align="left">rs2285666</td><td align="left">F: gtttgtaacccagataatcc</td><td align="left" rowspan="2"><italic>Alu</italic>I</td><td align="left" rowspan="2">130</td><td align="left" rowspan="2">C (130)</td><td align="left" rowspan="2">T (78, 52)</td><td align="left" rowspan="2">12% PAGE</td></tr><tr><td align="left"/><td align="left">R: gttgaaacacacatatctgc</td></tr><tr><td align="left">rs879922</td><td align="left">F: ttgtgttaagatcttgtccc</td><td align="left" rowspan="2"><italic>Bfa</italic>I</td><td align="left" rowspan="2">188</td><td align="left" rowspan="2">C (188)</td><td align="left" rowspan="2">G (146, 42)</td><td align="left" rowspan="2">12% PAGE</td></tr><tr><td align="left"/><td align="left">R: aataaactgagctccagc</td></tr><tr><td align="left">rs4646179</td><td align="left">F: tacagggaggaggatgtgcg</td><td align="left" rowspan="2"><italic>Hpy</italic>CH4IV</td><td align="left" rowspan="2">680</td><td align="left" rowspan="2">T (328, 229, 123)</td><td align="left" rowspan="2">C (328, 152, 123, 77)</td><td align="left" rowspan="2">2.5% Agarose electrophoresis</td></tr><tr><td align="left"/><td align="left">R: tgatggcaatacctgtccacg</td></tr></tbody></table><table-wrap-foot><p textid="17"><italic>bp</italic> base pairs, <italic>PAGE</italic> polyacrylamide gel electrophoresis</p></table-wrap-foot></table-wrap>
ACE2 genomic regions containing the variants of interest were PCR amplified from subjects' genomic DNA using standard methodology (Moolman-Smook et al. 1999); primers and annealing temperature used are given in Table 1. Variants were genotyped by allele-specific restriction enzyme digestion of the PCR amplicons and fragment sizes detected by gel electrophoresis (Table 1). Two independent observers, blinded to phenotypic data, performed allele-calling. Ten percent of samples, randomly selected for each amplicon, were nucleotide sequenced to verify genotyping results. Furthermore, Mendelian inheritance within families was assessed by Pedstats, using X-chromosome settings, and inconsistencies were resolved by re-genotyping.Table 1Summary of PCR-based allele-specific restriction enzyme analysis used for genotyping of ACE2 variantsVariantPrimers (5'-3')Restriction enzymeAmplicon size (bp)Major allele sizes (bp)Minor allele sizes (bp)Detection methodrs1978124F: tcttcctggctccttctcagcSau96I1,044T (1044)C (962, 82)1.5% Agarose electrophoresisR: accacaatggcagagaaagggrs2285666F: gtttgtaacccagataatccAluI130C (130)T (78, 52)12% PAGER: gttgaaacacacatatctgcrs879922F: ttgtgttaagatcttgtcccBfaI188C (188)G (146, 42)12% PAGER: aataaactgagctccagcrs4646179F: tacagggaggaggatgtgcgHpyCH4IV680T (328, 229, 123)C (328, 152, 123, 77)2.5% Agarose electrophoresisR: tgatggcaatacctgtccacgbp base pairs, PAGE polyacrylamide gel electrophoresis
###end p 15
###begin p 16
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
Summary of PCR-based allele-specific restriction enzyme analysis used for genotyping of ACE2 variants
###end p 16
###begin p 17
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bp</italic>
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAGE</italic>
bp base pairs, PAGE polyacrylamide gel electrophoresis
###end p 17
###begin title 18
Statistical analyses
###end title 18
###begin p 19
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2006</xref>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 1101 1105 1101 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2005</xref>
Quantile normalization was used to convert each trait to approximate normality (Pilia et al. 2006). Associations of ACE2 variants with heritable hypertrophy traits, viz. left ventricular mass (LVM), maximum interventricular septal thickness (maxIVS) and maximum posterior wall thickness (maxPW), were assessed with specialized mixed-effects models utilizing per-individual random effects which are correlated according to kinship coefficients (R package kinship, function lmekin). These models include variance components for environment and polygenes. Furthermore, concomitant adjustment was made for factors known to influence cardiac hypertrophy, viz. age, sex, body surface area, heart rate, systolic and diastolic blood pressure, hypertension diagnosis, as well as the identity of the disease-causing mutation, by including these as covariates in the analyses. We then formally tested the interaction between sex and genotype, after modeling the genotypes as the number of minor alleles (additive term), and a dominance term, which was only non-zero for heterozygous females (Cordell and Clayton 2005). This model is equivalent to modeling the genotypes as categories, labeling the male genotypes differently to the female genotypes. When the interaction between sex and genotype was not statistically significant, it was discarded from the model. The dominance term was similarly discarded if not significantly different from zero. The resulting models are summarized and discussed.
###end p 19
###begin p 20
As effect sizes derived from analysis of transformed data cannot be interpreted in terms of the original measurement units, we also modeled the raw data in terms of the genotypes of the associated variant rs879922, with adjustment for confounders and to obtain informative effect sizes. Because there were only two GG homozygotes in the group, we combined them with the heterozygotes to estimate the effect of at least one G-allele.
###end p 20
###begin p 21
Linkage disequilibrium between the four markers and Hardy-Weinberg equilibrium in the study cohort was assessed by Haploview vs3.32.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNNT2</italic>
###xml 56 61 56 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TNNT2</italic></sub>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYH7</italic>
###xml 70 74 70 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>MYH7</italic></sub>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYH7</italic>
###xml 87 91 87 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>MYH7</italic></sub>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 318 325 318 325 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 325 440 325 440 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24">Basic statistics of relevant clinical and demographic traits in the study cohort, stratified by HCM-mutation status</p>
###xml 325 440 325 440 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24">Basic statistics of relevant clinical and demographic traits in the study cohort, stratified by HCM-mutation status</p></caption>
###xml 440 440 440 440 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3"/>
###xml 440 460 440 460 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">HCM-mutation bearers</th>
###xml 460 468 460 468 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Controls</th>
###xml 440 468 440 468 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="3"/><th align="left" colspan="2">HCM-mutation bearers</th><th align="left" colspan="2">Controls</th></tr>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 468 475 468 475 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2"><italic>N</italic>&#160;=&#160;127</th>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 475 482 475 482 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2"><italic>N</italic>&#160;=&#160;100</th>
###xml 468 482 468 482 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;127</th><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;100</th></tr>
###xml 482 488 482 488 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median</th>
###xml 488 495 488 495 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(Q1,Q3)</th>
###xml 495 501 495 501 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median</th>
###xml 501 508 501 508 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(Q1,Q3)</th>
###xml 482 508 482 508 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Median</th><th align="left">(Q1,Q3)</th><th align="left">Median</th><th align="left">(Q1,Q3)</th></tr>
###xml 440 508 440 508 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="3"/><th align="left" colspan="2">HCM-mutation bearers</th><th align="left" colspan="2">Controls</th></tr><tr><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;127</th><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;100</th></tr><tr><th align="left">Median</th><th align="left">(Q1,Q3)</th><th align="left">Median</th><th align="left">(Q1,Q3)</th></tr></thead>
###xml 508 519 508 519 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age (years)</td>
###xml 519 521 519 521 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">41</td>
###xml 521 528 521 528 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(25,53)</td>
###xml 528 530 528 530 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">41</td>
###xml 530 537 530 537 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(29,51)</td>
###xml 508 537 508 537 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age (years)</td><td align="left">41</td><td align="left">(25,53)</td><td align="left">41</td><td align="left">(29,51)</td></tr>
###xml 546 547 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 537 548 537 548 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BSA (kg/m<sup>2</sup>)</td>
###xml 548 551 548 551 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.8</td>
###xml 551 560 551 560 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(1.6,2.0)</td>
###xml 560 563 560 563 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.8</td>
###xml 563 572 563 572 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(1.7,2.0)</td>
###xml 537 572 537 572 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BSA (kg/m<sup>2</sup>)</td><td align="left">1.8</td><td align="left">(1.6,2.0)</td><td align="left">1.8</td><td align="left">(1.7,2.0)</td></tr>
###xml 572 586 572 586 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SystBP (mm&#160;Hg)</td>
###xml 586 589 586 589 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">120</td>
###xml 589 598 589 598 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(110,130)</td>
###xml 598 601 598 601 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">120</td>
###xml 601 610 601 610 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(110,130)</td>
###xml 572 610 572 610 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">SystBP (mm&#160;Hg)</td><td align="left">120</td><td align="left">(110,130)</td><td align="left">120</td><td align="left">(110,130)</td></tr>
###xml 610 625 610 625 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">DiastBP (mm&#160;Hg)</td>
###xml 625 627 625 627 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">80</td>
###xml 627 634 627 634 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(70,80)</td>
###xml 634 636 634 636 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">80</td>
###xml 636 643 636 643 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(70,90)</td>
###xml 610 643 610 643 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">DiastBP (mm&#160;Hg)</td><td align="left">80</td><td align="left">(70,80)</td><td align="left">80</td><td align="left">(70,90)</td></tr>
###xml 643 659 643 659 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Heart rate (bpm)</td>
###xml 659 661 659 661 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">66</td>
###xml 661 668 661 668 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(60,75)</td>
###xml 668 670 668 670 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">69</td>
###xml 670 677 670 677 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(62,76)</td>
###xml 643 677 643 677 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Heart rate (bpm)</td><td align="left">66</td><td align="left">(60,75)</td><td align="left">69</td><td align="left">(62,76)</td></tr>
###xml 677 684 677 684 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LVM (g)</td>
###xml 684 687 684 687 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">166</td>
###xml 687 696 687 696 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(125,218)</td>
###xml 696 699 696 699 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">126</td>
###xml 699 708 699 708 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(103,158)</td>
###xml 677 708 677 708 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">LVM (g)</td><td align="left">166</td><td align="left">(125,218)</td><td align="left">126</td><td align="left">(103,158)</td></tr>
###xml 708 718 708 718 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">mIVST (mm)</td>
###xml 718 722 718 722 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13.9</td>
###xml 722 733 722 733 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(10.4,19.6)</td>
###xml 733 737 733 737 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10.2</td>
###xml 737 747 737 747 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(9.0,11.3)</td>
###xml 708 747 708 747 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">mIVST (mm)</td><td align="left">13.9</td><td align="left">(10.4,19.6)</td><td align="left">10.2</td><td align="left">(9.0,11.3)</td></tr>
###xml 747 755 747 755 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">mPW (mm)</td>
###xml 755 759 755 759 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10.1</td>
###xml 759 769 759 769 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(9.0,11.6)</td>
###xml 769 772 769 772 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9.0</td>
###xml 772 781 772 781 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(8.0,9.7)</td>
###xml 747 781 747 781 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">mPW (mm)</td><td align="left">10.1</td><td align="left">(9.0,11.6)</td><td align="left">9.0</td><td align="left">(8.0,9.7)</td></tr>
###xml 508 781 508 781 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Age (years)</td><td align="left">41</td><td align="left">(25,53)</td><td align="left">41</td><td align="left">(29,51)</td></tr><tr><td align="left">BSA (kg/m<sup>2</sup>)</td><td align="left">1.8</td><td align="left">(1.6,2.0)</td><td align="left">1.8</td><td align="left">(1.7,2.0)</td></tr><tr><td align="left">SystBP (mm&#160;Hg)</td><td align="left">120</td><td align="left">(110,130)</td><td align="left">120</td><td align="left">(110,130)</td></tr><tr><td align="left">DiastBP (mm&#160;Hg)</td><td align="left">80</td><td align="left">(70,80)</td><td align="left">80</td><td align="left">(70,90)</td></tr><tr><td align="left">Heart rate (bpm)</td><td align="left">66</td><td align="left">(60,75)</td><td align="left">69</td><td align="left">(62,76)</td></tr><tr><td align="left">LVM (g)</td><td align="left">166</td><td align="left">(125,218)</td><td align="left">126</td><td align="left">(103,158)</td></tr><tr><td align="left">mIVST (mm)</td><td align="left">13.9</td><td align="left">(10.4,19.6)</td><td align="left">10.2</td><td align="left">(9.0,11.3)</td></tr><tr><td align="left">mPW (mm)</td><td align="left">10.1</td><td align="left">(9.0,11.6)</td><td align="left">9.0</td><td align="left">(8.0,9.7)</td></tr></tbody>
###xml 440 781 440 781 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"/><th align="left" colspan="2">HCM-mutation bearers</th><th align="left" colspan="2">Controls</th></tr><tr><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;127</th><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;100</th></tr><tr><th align="left">Median</th><th align="left">(Q1,Q3)</th><th align="left">Median</th><th align="left">(Q1,Q3)</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">41</td><td align="left">(25,53)</td><td align="left">41</td><td align="left">(29,51)</td></tr><tr><td align="left">BSA (kg/m<sup>2</sup>)</td><td align="left">1.8</td><td align="left">(1.6,2.0)</td><td align="left">1.8</td><td align="left">(1.7,2.0)</td></tr><tr><td align="left">SystBP (mm&#160;Hg)</td><td align="left">120</td><td align="left">(110,130)</td><td align="left">120</td><td align="left">(110,130)</td></tr><tr><td align="left">DiastBP (mm&#160;Hg)</td><td align="left">80</td><td align="left">(70,80)</td><td align="left">80</td><td align="left">(70,90)</td></tr><tr><td align="left">Heart rate (bpm)</td><td align="left">66</td><td align="left">(60,75)</td><td align="left">69</td><td align="left">(62,76)</td></tr><tr><td align="left">LVM (g)</td><td align="left">166</td><td align="left">(125,218)</td><td align="left">126</td><td align="left">(103,158)</td></tr><tr><td align="left">mIVST (mm)</td><td align="left">13.9</td><td align="left">(10.4,19.6)</td><td align="left">10.2</td><td align="left">(9.0,11.3)</td></tr><tr><td align="left">mPW (mm)</td><td align="left">10.1</td><td align="left">(9.0,11.6)</td><td align="left">9.0</td><td align="left">(8.0,9.7)</td></tr></tbody></table>
###xml 781 944 781 944 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Because of the skewness of some distributions, data are summarised here as median (interquartile range), and were quantile normalized prior to association analysis</p>
###xml 946 947 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 950 951 950 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 956 957 956 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 976 977 976 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 944 1237 944 1237 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">(Q<sub>1</sub>, Q<sub>3</sub>)&#160;=&#160;Q<sub>1</sub>, first quartile, Q<sub>3</sub>, third quartile; BSA, body surface area; Syst, systolic; BP, blood pressure; Diast, diastolic; bpm, beats per minute; LVM, left ventricular mass; g, grams; mIVST, maximum interventricular septal thickness; mm, millimeter; mPW, maximum posterior wall thickness</p>
###xml 781 1237 781 1237 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Because of the skewness of some distributions, data are summarised here as median (interquartile range), and were quantile normalized prior to association analysis</p><p textid="26">(Q<sub>1</sub>, Q<sub>3</sub>)&#160;=&#160;Q<sub>1</sub>, first quartile, Q<sub>3</sub>, third quartile; BSA, body surface area; Syst, systolic; BP, blood pressure; Diast, diastolic; bpm, beats per minute; LVM, left ventricular mass; g, grams; mIVST, maximum interventricular septal thickness; mm, millimeter; mPW, maximum posterior wall thickness</p></table-wrap-foot>
###xml 318 1237 318 1237 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="24">Basic statistics of relevant clinical and demographic traits in the study cohort, stratified by HCM-mutation status</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"/><th align="left" colspan="2">HCM-mutation bearers</th><th align="left" colspan="2">Controls</th></tr><tr><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;127</th><th align="left" colspan="2"><italic>N</italic>&#160;=&#160;100</th></tr><tr><th align="left">Median</th><th align="left">(Q1,Q3)</th><th align="left">Median</th><th align="left">(Q1,Q3)</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">41</td><td align="left">(25,53)</td><td align="left">41</td><td align="left">(29,51)</td></tr><tr><td align="left">BSA (kg/m<sup>2</sup>)</td><td align="left">1.8</td><td align="left">(1.6,2.0)</td><td align="left">1.8</td><td align="left">(1.7,2.0)</td></tr><tr><td align="left">SystBP (mm&#160;Hg)</td><td align="left">120</td><td align="left">(110,130)</td><td align="left">120</td><td align="left">(110,130)</td></tr><tr><td align="left">DiastBP (mm&#160;Hg)</td><td align="left">80</td><td align="left">(70,80)</td><td align="left">80</td><td align="left">(70,90)</td></tr><tr><td align="left">Heart rate (bpm)</td><td align="left">66</td><td align="left">(60,75)</td><td align="left">69</td><td align="left">(62,76)</td></tr><tr><td align="left">LVM (g)</td><td align="left">166</td><td align="left">(125,218)</td><td align="left">126</td><td align="left">(103,158)</td></tr><tr><td align="left">mIVST (mm)</td><td align="left">13.9</td><td align="left">(10.4,19.6)</td><td align="left">10.2</td><td align="left">(9.0,11.3)</td></tr><tr><td align="left">mPW (mm)</td><td align="left">10.1</td><td align="left">(9.0,11.6)</td><td align="left">9.0</td><td align="left">(8.0,9.7)</td></tr></tbody></table><table-wrap-foot><p textid="25">Because of the skewness of some distributions, data are summarised here as median (interquartile range), and were quantile normalized prior to association analysis</p><p textid="26">(Q<sub>1</sub>, Q<sub>3</sub>)&#160;=&#160;Q<sub>1</sub>, first quartile, Q<sub>3</sub>, third quartile; BSA, body surface area; Syst, systolic; BP, blood pressure; Diast, diastolic; bpm, beats per minute; LVM, left ventricular mass; g, grams; mIVST, maximum interventricular septal thickness; mm, millimeter; mPW, maximum posterior wall thickness</p></table-wrap-foot></table-wrap>
Three hundred and twenty individuals belonging to 7 R92WTNNT2, 3 R403WMYH7 and 12 A797TMYH7 families were genotyped for variants in ACE2; of these, 227 individuals, including all HCM mutation-carriers, consented to clinical investigation; clinical and demographic traits of these individuals are summarized in Table 2.Table 2Basic statistics of relevant clinical and demographic traits in the study cohort, stratified by HCM-mutation statusHCM-mutation bearersControlsN = 127N = 100Median(Q1,Q3)Median(Q1,Q3)Age (years)41(25,53)41(29,51)BSA (kg/m2)1.8(1.6,2.0)1.8(1.7,2.0)SystBP (mm Hg)120(110,130)120(110,130)DiastBP (mm Hg)80(70,80)80(70,90)Heart rate (bpm)66(60,75)69(62,76)LVM (g)166(125,218)126(103,158)mIVST (mm)13.9(10.4,19.6)10.2(9.0,11.3)mPW (mm)10.1(9.0,11.6)9.0(8.0,9.7)Because of the skewness of some distributions, data are summarised here as median (interquartile range), and were quantile normalized prior to association analysis(Q1, Q3) = Q1, first quartile, Q3, third quartile; BSA, body surface area; Syst, systolic; BP, blood pressure; Diast, diastolic; bpm, beats per minute; LVM, left ventricular mass; g, grams; mIVST, maximum interventricular septal thickness; mm, millimeter; mPW, maximum posterior wall thickness
###end p 23
###begin p 24
Basic statistics of relevant clinical and demographic traits in the study cohort, stratified by HCM-mutation status
###end p 24
###begin p 25
Because of the skewness of some distributions, data are summarised here as median (interquartile range), and were quantile normalized prior to association analysis
###end p 25
###begin p 26
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
(Q1, Q3) = Q1, first quartile, Q3, third quartile; BSA, body surface area; Syst, systolic; BP, blood pressure; Diast, diastolic; bpm, beats per minute; LVM, left ventricular mass; g, grams; mIVST, maximum interventricular septal thickness; mm, millimeter; mPW, maximum posterior wall thickness
###end p 26
###begin p 27
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 228 229 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 230 237 228 235 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 237 326 235 324 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Genotype frequencies for ACE2 variants in the complete study cohort, stratified by gender</p>
###xml 237 326 235 324 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Genotype frequencies for ACE2 variants in the complete study cohort, stratified by gender</p></caption>
###xml 326 326 324 324 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 326 330 324 328 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Male</th>
###xml 330 336 328 334 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">Female</th>
###xml 326 336 324 334 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left" colspan="2">Male</th><th align="left" colspan="3">Female</th></tr>
###xml 336 337 334 335 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">C</th>
###xml 337 338 335 336 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G</th>
###xml 338 340 336 338 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CC</th>
###xml 340 342 338 340 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CG</th>
###xml 342 344 340 342 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">GG</th>
###xml 336 344 334 342 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">C</th><th align="left">G</th><th align="left">CC</th><th align="left">CG</th><th align="left">GG</th></tr>
###xml 326 344 324 342 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left" colspan="2">Male</th><th align="left" colspan="3">Female</th></tr><tr><th align="left">C</th><th align="left">G</th><th align="left">CC</th><th align="left">CG</th><th align="left">GG</th></tr></thead>
###xml 344 353 342 351 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs1978124</td>
###xml 353 357 351 355 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.38</td>
###xml 357 361 355 359 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.62</td>
###xml 361 365 359 363 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.16</td>
###xml 365 369 363 367 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.31</td>
###xml 369 373 367 371 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.53</td>
###xml 344 373 342 371 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs1978124</td><td char="." align="char">0.38</td><td char="." align="char">0.62</td><td char="." align="char">0.16</td><td char="." align="char">0.31</td><td char="." align="char">0.53</td></tr>
###xml 373 382 371 380 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs2285666</td>
###xml 382 386 380 384 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.81</td>
###xml 386 390 384 388 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.19</td>
###xml 390 394 388 392 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.59</td>
###xml 394 398 392 396 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.38</td>
###xml 398 402 396 400 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.03</td>
###xml 373 402 371 400 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs2285666</td><td char="." align="char">0.81</td><td char="." align="char">0.19</td><td char="." align="char">0.59</td><td char="." align="char">0.38</td><td char="." align="char">0.03</td></tr>
###xml 402 410 400 408 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs879922</td>
###xml 410 414 408 412 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.77</td>
###xml 414 418 412 416 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.23</td>
###xml 418 422 416 420 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.50</td>
###xml 422 426 420 424 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.49</td>
###xml 426 430 424 428 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.01</td>
###xml 402 430 400 428 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs879922</td><td char="." align="char">0.77</td><td char="." align="char">0.23</td><td char="." align="char">0.50</td><td char="." align="char">0.49</td><td char="." align="char">0.01</td></tr>
###xml 430 439 428 437 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs4646179</td>
###xml 439 443 437 441 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.98</td>
###xml 443 447 441 445 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 447 451 445 449 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.98</td>
###xml 451 455 449 453 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 455 459 453 457 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.00</td>
###xml 430 459 428 457 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs4646179</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.00</td></tr>
###xml 344 459 342 457 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">rs1978124</td><td char="." align="char">0.38</td><td char="." align="char">0.62</td><td char="." align="char">0.16</td><td char="." align="char">0.31</td><td char="." align="char">0.53</td></tr><tr><td align="left">rs2285666</td><td char="." align="char">0.81</td><td char="." align="char">0.19</td><td char="." align="char">0.59</td><td char="." align="char">0.38</td><td char="." align="char">0.03</td></tr><tr><td align="left">rs879922</td><td char="." align="char">0.77</td><td char="." align="char">0.23</td><td char="." align="char">0.50</td><td char="." align="char">0.49</td><td char="." align="char">0.01</td></tr><tr><td align="left">rs4646179</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.00</td></tr></tbody>
###xml 326 459 324 457 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2">Male</th><th align="left" colspan="3">Female</th></tr><tr><th align="left">C</th><th align="left">G</th><th align="left">CC</th><th align="left">CG</th><th align="left">GG</th></tr></thead><tbody><tr><td align="left">rs1978124</td><td char="." align="char">0.38</td><td char="." align="char">0.62</td><td char="." align="char">0.16</td><td char="." align="char">0.31</td><td char="." align="char">0.53</td></tr><tr><td align="left">rs2285666</td><td char="." align="char">0.81</td><td char="." align="char">0.19</td><td char="." align="char">0.59</td><td char="." align="char">0.38</td><td char="." align="char">0.03</td></tr><tr><td align="left">rs879922</td><td char="." align="char">0.77</td><td char="." align="char">0.23</td><td char="." align="char">0.50</td><td char="." align="char">0.49</td><td char="." align="char">0.01</td></tr><tr><td align="left">rs4646179</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.00</td></tr></tbody></table>
###xml 230 459 228 457 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="28">Genotype frequencies for ACE2 variants in the complete study cohort, stratified by gender</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2">Male</th><th align="left" colspan="3">Female</th></tr><tr><th align="left">C</th><th align="left">G</th><th align="left">CC</th><th align="left">CG</th><th align="left">GG</th></tr></thead><tbody><tr><td align="left">rs1978124</td><td char="." align="char">0.38</td><td char="." align="char">0.62</td><td char="." align="char">0.16</td><td char="." align="char">0.31</td><td char="." align="char">0.53</td></tr><tr><td align="left">rs2285666</td><td char="." align="char">0.81</td><td char="." align="char">0.19</td><td char="." align="char">0.59</td><td char="." align="char">0.38</td><td char="." align="char">0.03</td></tr><tr><td align="left">rs879922</td><td char="." align="char">0.77</td><td char="." align="char">0.23</td><td char="." align="char">0.50</td><td char="." align="char">0.49</td><td char="." align="char">0.01</td></tr><tr><td align="left">rs4646179</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.98</td><td char="." align="char">0.02</td><td char="." align="char">0.00</td></tr></tbody></table></table-wrap>
All markers were in Hardy-Weinberg equilibrium in the unrelated individuals and there was no relevant correlation between the SNPs (all r2 </= 0.1). Genotype frequencies of the markers in the study population are given in Table 3.Table 3Genotype frequencies for ACE2 variants in the complete study cohort, stratified by genderMaleFemaleCGCCCGGGrs19781240.380.620.160.310.53rs22856660.810.190.590.380.03rs8799220.770.230.500.490.01rs46461790.980.020.980.020.00
###end p 27
###begin p 28
Genotype frequencies for ACE2 variants in the complete study cohort, stratified by gender
###end p 28
###begin p 29
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2005</xref>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 1026 1027 1026 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 1029 1036 1029 1036 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;4</label>
###xml 1080 1081 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1036 1133 1036 1133 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">Effect size (beta), standard error (SE) and <italic>P</italic> value for tests of association of variants in ACE2 </p>
###xml 1036 1133 1036 1133 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">Effect size (beta), standard error (SE) and <italic>P</italic> value for tests of association of variants in ACE2 </p></caption>
###xml 1133 1136 1133 1136 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">SNP</th>
###xml 1136 1143 1136 1143 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">LVMecho</th>
###xml 1143 1151 1143 1151 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">max IVST</th>
###xml 1151 1157 1151 1157 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">max PW</th>
###xml 1133 1157 1133 1157 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">SNP</th><th align="left" colspan="3">LVMecho</th><th align="left" colspan="3">max IVST</th><th align="left" colspan="3">max PW</th></tr>
###xml 1157 1161 1157 1161 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Beta</th>
###xml 1161 1163 1161 1163 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SE</th>
###xml 1163 1164 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1163 1170 1163 1170 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 1170 1174 1170 1174 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Beta</th>
###xml 1174 1176 1174 1176 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SE</th>
###xml 1176 1177 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1176 1183 1176 1183 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 1183 1187 1183 1187 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Beta</th>
###xml 1187 1189 1187 1189 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SE</th>
###xml 1189 1190 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1189 1196 1189 1196 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 1157 1196 1157 1196 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th></tr>
###xml 1133 1196 1133 1196 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">SNP</th><th align="left" colspan="3">LVMecho</th><th align="left" colspan="3">max IVST</th><th align="left" colspan="3">max PW</th></tr><tr><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th></tr></thead>
###xml 1196 1205 1196 1205 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs1978124</td>
###xml 1205 1209 1205 1209 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;8.0</td>
###xml 1209 1212 1209 1212 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.9</td>
###xml 1212 1218 1212 1218 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.1190</td>
###xml 1218 1223 1218 1223 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;1.14</td>
###xml 1223 1227 1223 1227 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.62</td>
###xml 1227 1233 1227 1233 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2448</td>
###xml 1233 1239 1233 1239 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.315</td>
###xml 1239 1244 1239 1244 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.234</td>
###xml 1244 1250 1244 1250 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0772</td>
###xml 1196 1250 1196 1250 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs1978124</td><td char="." align="char">&#8722;8.0</td><td char="." align="char">5.9</td><td char="." align="char">0.1190</td><td char="." align="char">&#8722;1.14</td><td char="." align="char">0.62</td><td char="." align="char">0.2448</td><td char="." align="char">&#8722;0.315</td><td char="." align="char">0.234</td><td char="." align="char">0.0772</td></tr>
###xml 1250 1259 1250 1259 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs2285666</td>
###xml 1259 1262 1259 1262 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.7</td>
###xml 1262 1265 1262 1265 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.5</td>
###xml 1265 1271 1265 1271 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.6544</td>
###xml 1271 1275 1271 1275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 1275 1279 1275 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.80</td>
###xml 1279 1285 1279 1285 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.7796</td>
###xml 1285 1291 1285 1291 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.246</td>
###xml 1291 1296 1291 1296 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.276</td>
###xml 1296 1302 1296 1302 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.1825</td>
###xml 1250 1302 1250 1302 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs2285666</td><td char="." align="char">6.7</td><td char="." align="char">8.5</td><td char="." align="char">0.6544</td><td char="." align="char">0.02</td><td char="." align="char">0.80</td><td char="." align="char">0.7796</td><td char="." align="char">&#8722;0.246</td><td char="." align="char">0.276</td><td char="." align="char">0.1825</td></tr>
###xml 1302 1310 1302 1310 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs879922</td>
###xml 1310 1314 1310 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">18.7</td>
###xml 1314 1317 1314 1317 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.4</td>
###xml 1317 1323 1317 1323 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0205</td>
###xml 1323 1327 1323 1327 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.87</td>
###xml 1327 1331 1327 1331 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.87</td>
###xml 1331 1337 1331 1337 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0393</td>
###xml 1337 1342 1337 1342 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.657</td>
###xml 1342 1347 1342 1347 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.305</td>
###xml 1347 1353 1347 1353 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0090</td>
###xml 1302 1353 1302 1353 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs879922</td><td char="." align="char">18.7</td><td char="." align="char">9.4</td><td char="." align="char">0.0205</td><td char="." align="char">1.87</td><td char="." align="char">0.87</td><td char="." align="char">0.0393</td><td char="." align="char">0.657</td><td char="." align="char">0.305</td><td char="." align="char">0.0090</td></tr>
###xml 1353 1362 1353 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs4646179</td>
###xml 1362 1366 1362 1366 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26.9</td>
###xml 1366 1370 1366 1370 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27.0</td>
###xml 1370 1376 1370 1376 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.4813</td>
###xml 1376 1380 1376 1380 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.71</td>
###xml 1380 1384 1380 1384 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.56</td>
###xml 1384 1390 1384 1390 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2999</td>
###xml 1390 1395 1390 1395 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.154</td>
###xml 1395 1400 1395 1400 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.893</td>
###xml 1400 1406 1400 1406 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.6102</td>
###xml 1353 1406 1353 1406 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">rs4646179</td><td char="." align="char">26.9</td><td char="." align="char">27.0</td><td char="." align="char">0.4813</td><td char="." align="char">3.71</td><td char="." align="char">2.56</td><td char="." align="char">0.2999</td><td char="." align="char">0.154</td><td char="." align="char">0.893</td><td char="." align="char">0.6102</td></tr>
###xml 1196 1406 1196 1406 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">rs1978124</td><td char="." align="char">&#8722;8.0</td><td char="." align="char">5.9</td><td char="." align="char">0.1190</td><td char="." align="char">&#8722;1.14</td><td char="." align="char">0.62</td><td char="." align="char">0.2448</td><td char="." align="char">&#8722;0.315</td><td char="." align="char">0.234</td><td char="." align="char">0.0772</td></tr><tr><td align="left">rs2285666</td><td char="." align="char">6.7</td><td char="." align="char">8.5</td><td char="." align="char">0.6544</td><td char="." align="char">0.02</td><td char="." align="char">0.80</td><td char="." align="char">0.7796</td><td char="." align="char">&#8722;0.246</td><td char="." align="char">0.276</td><td char="." align="char">0.1825</td></tr><tr><td align="left">rs879922</td><td char="." align="char">18.7</td><td char="." align="char">9.4</td><td char="." align="char">0.0205</td><td char="." align="char">1.87</td><td char="." align="char">0.87</td><td char="." align="char">0.0393</td><td char="." align="char">0.657</td><td char="." align="char">0.305</td><td char="." align="char">0.0090</td></tr><tr><td align="left">rs4646179</td><td char="." align="char">26.9</td><td char="." align="char">27.0</td><td char="." align="char">0.4813</td><td char="." align="char">3.71</td><td char="." align="char">2.56</td><td char="." align="char">0.2999</td><td char="." align="char">0.154</td><td char="." align="char">0.893</td><td char="." align="char">0.6102</td></tr></tbody>
###xml 1133 1406 1133 1406 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">SNP</th><th align="left" colspan="3">LVMecho</th><th align="left" colspan="3">max IVST</th><th align="left" colspan="3">max PW</th></tr><tr><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">rs1978124</td><td char="." align="char">&#8722;8.0</td><td char="." align="char">5.9</td><td char="." align="char">0.1190</td><td char="." align="char">&#8722;1.14</td><td char="." align="char">0.62</td><td char="." align="char">0.2448</td><td char="." align="char">&#8722;0.315</td><td char="." align="char">0.234</td><td char="." align="char">0.0772</td></tr><tr><td align="left">rs2285666</td><td char="." align="char">6.7</td><td char="." align="char">8.5</td><td char="." align="char">0.6544</td><td char="." align="char">0.02</td><td char="." align="char">0.80</td><td char="." align="char">0.7796</td><td char="." align="char">&#8722;0.246</td><td char="." align="char">0.276</td><td char="." align="char">0.1825</td></tr><tr><td align="left">rs879922</td><td char="." align="char">18.7</td><td char="." align="char">9.4</td><td char="." align="char">0.0205</td><td char="." align="char">1.87</td><td char="." align="char">0.87</td><td char="." align="char">0.0393</td><td char="." align="char">0.657</td><td char="." align="char">0.305</td><td char="." align="char">0.0090</td></tr><tr><td align="left">rs4646179</td><td char="." align="char">26.9</td><td char="." align="char">27.0</td><td char="." align="char">0.4813</td><td char="." align="char">3.71</td><td char="." align="char">2.56</td><td char="." align="char">0.2999</td><td char="." align="char">0.154</td><td char="." align="char">0.893</td><td char="." align="char">0.6102</td></tr></tbody></table>
###xml 1526 1527 1526 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1406 1632 1406 1632 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Effect size and standard error are given in original units of measurement for traits, for ease of interpretation, while <italic>P</italic> values are for tests on quantile normalised traits. Beta is the effect on the trait of adding a G-allele</p>
###xml 1632 1635 1632 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LVM</italic>
###xml 1659 1666 1659 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maxIVST</italic>
###xml 1710 1715 1710 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maxPW</italic>
###xml 1632 1748 1632 1748 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><italic>LVM</italic> left ventricular mass, <italic>maxIVST</italic> maximum interventricular septal thickness, <italic>maxPW</italic> maximum posterior wall thickness</p>
###xml 1406 1748 1406 1748 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31">Effect size and standard error are given in original units of measurement for traits, for ease of interpretation, while <italic>P</italic> values are for tests on quantile normalised traits. Beta is the effect on the trait of adding a G-allele</p><p textid="32"><italic>LVM</italic> left ventricular mass, <italic>maxIVST</italic> maximum interventricular septal thickness, <italic>maxPW</italic> maximum posterior wall thickness</p></table-wrap-foot>
###xml 1029 1748 1029 1748 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table&#160;4</label><caption><p textid="30">Effect size (beta), standard error (SE) and <italic>P</italic> value for tests of association of variants in ACE2 </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">SNP</th><th align="left" colspan="3">LVMecho</th><th align="left" colspan="3">max IVST</th><th align="left" colspan="3">max PW</th></tr><tr><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th><th align="left">Beta</th><th align="left">SE</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">rs1978124</td><td char="." align="char">&#8722;8.0</td><td char="." align="char">5.9</td><td char="." align="char">0.1190</td><td char="." align="char">&#8722;1.14</td><td char="." align="char">0.62</td><td char="." align="char">0.2448</td><td char="." align="char">&#8722;0.315</td><td char="." align="char">0.234</td><td char="." align="char">0.0772</td></tr><tr><td align="left">rs2285666</td><td char="." align="char">6.7</td><td char="." align="char">8.5</td><td char="." align="char">0.6544</td><td char="." align="char">0.02</td><td char="." align="char">0.80</td><td char="." align="char">0.7796</td><td char="." align="char">&#8722;0.246</td><td char="." align="char">0.276</td><td char="." align="char">0.1825</td></tr><tr><td align="left">rs879922</td><td char="." align="char">18.7</td><td char="." align="char">9.4</td><td char="." align="char">0.0205</td><td char="." align="char">1.87</td><td char="." align="char">0.87</td><td char="." align="char">0.0393</td><td char="." align="char">0.657</td><td char="." align="char">0.305</td><td char="." align="char">0.0090</td></tr><tr><td align="left">rs4646179</td><td char="." align="char">26.9</td><td char="." align="char">27.0</td><td char="." align="char">0.4813</td><td char="." align="char">3.71</td><td char="." align="char">2.56</td><td char="." align="char">0.2999</td><td char="." align="char">0.154</td><td char="." align="char">0.893</td><td char="." align="char">0.6102</td></tr></tbody></table><table-wrap-foot><p textid="31">Effect size and standard error are given in original units of measurement for traits, for ease of interpretation, while <italic>P</italic> values are for tests on quantile normalised traits. Beta is the effect on the trait of adding a G-allele</p><p textid="32"><italic>LVM</italic> left ventricular mass, <italic>maxIVST</italic> maximum interventricular septal thickness, <italic>maxPW</italic> maximum posterior wall thickness</p></table-wrap-foot></table-wrap>
Statististically, there were no significant interactions between sex and genotype, so that no sex-specific effects of alleles were observed (results not shown). As the dominance term was not significantly different from zero, we could model the genotypes as single numerical factors, specified as the number of minor-alleles carried by the individual; thus males had a maximum of one of these alleles and females a maximum of two ("additive" coding) (Cordell and Clayton 2005). The P values for significance tests of the additive term, after removing the dominance term from the model, are shown in Table 4. While there was no evidence for association between hypertrophy traits and ACE2 SNPs rs1978124, rs2285666 or rs4646179, the G-allele of rs879922 was found to have a significant effect on all three of the investigated hypertrophic traits, increasing each by a modest amount. The effect sizes of the G-allele on untransformed, covariate-adjusted traits were 18.7 g for LVM, 1.9 mm for maxIVS and 0.7 mm for maxPW (Table 4).Table 4Effect size (beta), standard error (SE) and P value for tests of association of variants in ACE2 SNPLVMechomax IVSTmax PWBetaSEP valueBetaSEP valueBetaSEP valuers1978124-8.05.90.1190-1.140.620.2448-0.3150.2340.0772rs22856666.78.50.65440.020.800.7796-0.2460.2760.1825rs87992218.79.40.02051.870.870.03930.6570.3050.0090rs464617926.927.00.48133.712.560.29990.1540.8930.6102Effect size and standard error are given in original units of measurement for traits, for ease of interpretation, while P values are for tests on quantile normalised traits. Beta is the effect on the trait of adding a G-alleleLVM left ventricular mass, maxIVST maximum interventricular septal thickness, maxPW maximum posterior wall thickness
###end p 29
###begin p 30
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect size (beta), standard error (SE) and P value for tests of association of variants in ACE2 
###end p 30
###begin p 31
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect size and standard error are given in original units of measurement for traits, for ease of interpretation, while P values are for tests on quantile normalised traits. Beta is the effect on the trait of adding a G-allele
###end p 31
###begin p 32
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LVM</italic>
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maxIVST</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maxPW</italic>
LVM left ventricular mass, maxIVST maximum interventricular septal thickness, maxPW maximum posterior wall thickness
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
In this study, we used HCM families, in which the disease is caused by defined founder mutations, to assess the role of variants in ACE2 in hypertrophy development, independent of factors that are known to influence this phenomenon. We find that the G-allele of rs879922 is associated with increased hypertrophy, viz. increased LVM, maxIVS and maxPW.
###end p 34
###begin p 35
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2006</xref>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2008</xref>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
Lieb et al. previously reported association of the rs879922 G-allele, singly as well as within a four-marker haplotype (with rs4646156, rs4240157 and rs233575), with modestly increased LVM and maxIVS in the general male population in Augsburg, Germany (Lieb et al. 2006). Wang et al. recently reported association of other ACE2 variants, rs2106809 and rs663677, with maxIVS, again only in a group of male HCM patients, with unknown primary disease-causing mutations (Wang et al. 2008).
###end p 35
###begin p 36
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2004</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2006</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2008</xref>
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Although ACE2 maps to a hypertension quantitative trait locus identified in three different rat models of hypertension, no association between ACE2 variants and hypertension has been found to date (Benjafield et al. 2004; Lieb et al. 2006; Wang et al. 2008). In our study, association with hypertrophy was also independent of blood pressure per se or diagnosis of hypertension.
###end p 36
###begin p 37
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2003</xref>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> ACE2</italic>
Taken together, our data indicate a role for variation in ACE2 in modifying the development of left ventricular hypertrophy. Furthermore, the results suggest that the genetic modifiers of the cardiac hypertrophy that develops in response to a primary HCM-causing mutation may also be involved in hypertrophy development in the general population. The effect size of the G-allele of rs879922 is modest, as has been previously described for other RAAS gene variants (Mayosi et al. 2003), which may suggest that the hypertrophic phenotype is the cumulative result of a number of genes of moderate effect. As rs879922 occurs within an intron and does not have any obvious functional role, it is possible that the association noted in this study, as well as that of Lieb et al., indicates the effect of a functional variant in linkage disequilibrium with rs879922. The extent of variation in this gene and the LD distribution across the genome in the study population is unknown. However, rs879922 tags at least 2-8 additional HAPMAP SNPs in the CEU, YRI and JPT + CHB populations. In the CEU and YRI HAPMAP populations, variation in ACE2 is predominantly captured by two and three haplotype blocks, respectively; rs879922 is located within a haplotype block involving the 3' approximately third of the gene, which may indicate that the functional variant lies in this region of the gene.
###end p 37
###begin p 38
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2002</xref>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
Due to the highly variable distribution of left ventricular hypertrophy in HCM, it is difficult to distinguish a single echocardiographic measure that accurately quantifies the extent of hypertrophy in all patients. Although LVM is most often used to quantify hypertrophy in HCM, it is known to be an inaccurate measure when echocardiographically derived, due to the asymmetric nature of hypertrophy in HCM. Thus, we also investigated hypertrophic traits that are heritable (Mayosi et al. 2002) and can be directly measured, viz. maxIVS and maxPW, rather than calculated from geometric assumptions.
###end p 38
###begin p 39
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2002</xref>
We did not employ Bonferroni correction for multiple testing, as the traits investigated are highly correlated, and such correction is considered over-conservative, risking the rejection of important findings, while Bayesian methods for correction rely on knowledge of prior probability of involvement, which is currently unknown for most genetic variants (Campbell and Rudan 2002). However, even if the over-stringent Bonferroni correction for four independent tests (for the four markers) were performed, the association noted for rs879922 with maxPW would remain significant, and that with LVM remain a trend.
###end p 39
###begin p 40
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE2</italic>
###xml 693 694 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">.</italic>
###xml 709 710 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">.</italic>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
Although the number of subjects assessed in this study is modest, our data adds to previous investigations in confirming the involvement of ACE2 in the development of cardiac hypertrophy, independent of blood pressure or indeed other hypertrophy covariates, in HCM patients. Furthermore, in our study, the use of data derived from HCM families carrying known, founder mutations afforded benefits over case-control studies, such as additional control of genotyping accuracy, control over the variability introduced by distinct primary disease-causing mutations, and avoidance of the confounding effect of occult population stratification. Furthermore, our study combined with that of Lieb et al. and Wang et al. supports a more consistent role for the recently identified component of RAAS, ACEII, than the discordant findings for the original ACEI, in modulating cardiac hypertrophy, and in particular in modifying the extent of hypertrophy that develops in response to HCM-causing mutations.
###end p 40
###begin p 41
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro Deo</italic>
GE Healthcare (Germany) is thanked for the pro Deo use of a Vivid7 cardiovascular ultrasound system for the duration of the study. This work was funded by the Wellcome Trust (International senior research fellowship GR073610MA to JCM-S) and the South African National Research Foundation (FA2006040300007 to JCM-S.).
###end p 41
###begin p 42
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 42
###begin title 43
References
###end title 43
###begin article-title 44
No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension
###end article-title 44
###begin article-title 45
Interpretation of genetic association studies in complex disease
###end article-title 45
###begin article-title 46
Genetic association studies
###end article-title 46
###begin article-title 47
###xml 124 127 <span type="species:ncbi:9606">men</span>
Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy
###end article-title 47
###begin article-title 48
Association of angiotensin I converting enzyme 2 gene polymorphism with essential hypertension in Chinese
###end article-title 48
###begin article-title 49
Modifier genes for hypertrophic cardiomyopathy
###end article-title 49
###begin article-title 50
Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass
###end article-title 50
###begin article-title 51
Measured haplotype analysis of the aldosterone synthase gene and heart size
###end article-title 51
###begin article-title 52
The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events
###end article-title 52
###begin article-title 53
Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene
###end article-title 53
###begin article-title 54
Heritability of cardiovascular and personality traits in 6, 148 Sardinians
###end article-title 54
###begin article-title 55
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy
###end article-title 55
###begin article-title 56
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
###end article-title 56
###begin article-title 57
###xml 66 72 <span type="species:ncbi:10090">murine</span>
A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy
###end article-title 57
###begin article-title 58
###xml 120 128 <span type="species:ncbi:9606">patients</span>
Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy
###end article-title 58
###begin article-title 59
Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population
###end article-title 59

